Compass Therapeutics, Inc.
NASDAQ: CMPX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Thomas J. Schuetz
- Employees
- 35
- Headquarters
- Boston, United States
- IPO year
- 2021
- Market cap
- $279.3M
- Website
- https://www.compasstherapeutics.com
Loading CMPX…
Loading profile data…Frequently asked questions about CMPX
What does Compass Therapeutics, Inc. (CMPX) do?
Compass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials. The company's work involves creating antibody-based medicines designed to address a variety of human health conditions. Among its leading clinical-stage programs are CTX-009, an experim...
Where does CMPX trade?
Compass Therapeutics, Inc. (CMPX) trades on the NASDAQ Capital Market.
What sector is CMPX in?
Compass Therapeutics, Inc. (CMPX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Compass Therapeutics, Inc.?
Thomas J. Schuetz is the chief executive officer of Compass Therapeutics, Inc. (CMPX).
Where is Compass Therapeutics, Inc. headquartered?
Compass Therapeutics, Inc. is headquartered in United States.
Does CMPX pay a dividend?
Compass Therapeutics, Inc. (CMPX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CMPX go public?
Compass Therapeutics, Inc. (CMPX) completed its initial public offering in 2021.